Quanterix Corporation Provision for Loan, Lease, and Other Losses
Quanterix Corporation (QTRX) reported Provision for Loan, Lease, and Other Losses of $990.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2026-08-10
- Quanterix Corporation provision for loan, lease, and other losses for the quarter ending 2026-06-30 was $462.00K, a 144.44% increase year-over-year.
- Quanterix Corporation provision for loan, lease, and other losses for the quarter ending 2026-03-31 was $528.00K, a 183.87% increase year-over-year.
- Quanterix Corporation provision for loan, lease, and other losses for the quarter ending 2025-12-31 was $1.00M.
- Quanterix Corporation provision for loan, lease, and other losses for the quarter ending 2025-09-30 was $86.00K, a 26.47% increase year-over-year.
- Quanterix Corporation provision for loan, lease, and other losses for fiscal 2025 was $1.47M, a 105.76% increase from fiscal 2024.
- Quanterix Corporation provision for loan, lease, and other losses for fiscal 2024 was $712.00K, a 2.33% decline from fiscal 2023.
- Quanterix Corporation provision for loan, lease, and other losses for fiscal 2023 was $729.00K, a 3.06% decline from fiscal 2022.
- Quanterix Corporation provision for loan, lease, and other losses for fiscal 2022 was $752.00K, a 253.05% increase from fiscal 2021.
| Period end | Provision for Loan, Lease, and Other Losses 3 month | Provision for Loan, Lease, and Other Losses 3 month as first filed | Provision for Loan, Lease, and Other Losses 6 month | Provision for Loan, Lease, and Other Losses 6 month as first filed | Provision for Loan, Lease, and Other Losses 9 month | Provision for Loan, Lease, and Other Losses 9 month as first filed | Provision for Loan, Lease, and Other Losses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $990.00K 10-Q · filed 2026-08-10 | $1.99M derived: sum of 3 quarters · filed 2026-08-10 | $2.08M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $528.00K 10-Q · filed 2026-05-06 | $1.53M derived: sum of 2 quarters · filed 2026-05-06 | $1.62M derived: sum of 3 quarters · filed 2026-05-06 | $1.81M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.09M derived: sum of 2 quarters · filed 2026-03-02 | $1.28M derived: sum of 3 quarters · filed 2026-08-10 | $1.47M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $275.00K derived: sum of 2 quarters · filed 2026-08-10 | $461.00K 10-Q · filed 2025-11-10 | $429.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $375.00K 10-Q · filed 2026-08-10 | $343.00K derived: sum of 3 quarters · filed 2026-08-10 | $411.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $186.00K 10-Q · filed 2026-05-06 | $154.00K derived: sum of 2 quarters · filed 2026-05-06 | $222.00K derived: sum of 3 quarters · filed 2026-05-06 | $722.00K derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $36.00K derived: sum of 2 quarters · filed 2026-03-02 | $536.00K derived: sum of 3 quarters · filed 2026-03-02 | $712.00K 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $568.00K derived: sum of 2 quarters · filed 2025-11-10 | $744.00K 10-Q · filed 2025-11-10 | $868.00K derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $676.00K 10-Q · filed 2025-08-07 | $800.00K derived: sum of 3 quarters · filed 2026-03-02 | $889.00K derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | $176.00K 10-Q · filed 2025-05-12 | -$176.00K 10-Q · filed 2024-05-08 | $300.00K derived: sum of 2 quarters · filed 2026-03-02 | $389.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.08M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $213.00K derived: sum of 2 quarters · filed 2026-03-02 | $907.00K derived: sum of 3 quarters · filed 2026-03-02 | $729.00K 10-K · filed 2026-03-02 | |||
| 2023-09-30 | $89.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-12-26 | $783.00K derived: sum of 2 quarters · filed 2024-12-26 | $605.00K 10-Q · filed 2024-12-26 | -$605.00K 10-Q · filed 2023-11-08 | $1.46M derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2023-06-30 | $694.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-12-26 | $516.00K 10-Q/A · filed 2024-12-26 | -$516.00K 10-Q · filed 2023-08-08 | $1.37M derived: sum of 3 quarters · filed 2025-03-17 | $1.85M derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2023-03-31 | -$178.00K 10-Q/A · filed 2024-12-26 | $676.00K derived: sum of 2 quarters · filed 2025-03-17 | $1.16M derived: sum of 3 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | $854.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $1.33M derived: sum of 2 quarters · filed 2025-03-17 | $752.00K 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | $479.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$102.00K 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | -$581.00K 10-Q · filed 2023-08-08 | ||||||
| 2021-12-31 | $213.00K 10-K/A · filed 2024-12-26 | ||||||
| 2020-12-31 | $493.00K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |